Biotech companies by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Biogen has the lowest figure of the 19 biotech companies ranked by P/S ratio, at 3.7, followed by Qiagen (4.9) and Neurocrine Biosciences (5.8). Figures as of 18 Nov 2026, 16:47 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
Lowest
Biogen3.7
Median
14.3
Combined market value
PLN 3.38T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

All countries
All sectors
Biotech
PLN
Clear filters
Biotech companies by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care3.7PLN 148.7BPLN 1,006.07 0.34% down 49% up United States
2QiagenQGEN · Health Care4.9PLN 41.2BPLN 199.41 0.42% down 12% up Netherlands
3Neurocrine BiosciencesNBIX · Health Care5.8PLN 66.3BPLN 654.65 1.98% down 20% up United States
4BioNTechBNTX · Health Care6.6PLN 84BPLN 338.68 0.85% down 16% down Germany
5AmgenAMGN · Health Care6.6PLN 973BPLN 1,798.86 2.41% down 34% up United States
6Gilead SciencesGILD · Health Care7.1PLN 845.5BPLN 681.64 0.54% down 33% up United States
7ExelixisEXEL · Health Care7.3PLN 67.8BPLN 278.05 0.84% up 63% up United States
8Halozyme TherapeuticsHALO · Health Care7.9PLN 44.5BPLN 390.24 1.02% up 37% up United States
9Bio-TechneTECH · Health Care9.4PLN 46BPLN 292.73 0.13% up 26% up United States
10argenxARGX · Health Care14.3PLN 238.4BPLN 3,791.09 0.60% down 4% up Belgium
11RepligenRGEN · Health Care14.7PLN 43.7BPLN 683.83 4.75% up 5% up United States
12Adaptive BiotechnologiesADPT · Health Care16.4PLN 18.3BPLN 113.07 1.40% down 88% up United States
13Twist BioscienceTWST · Health Care20.8PLN 31.6BPLN 463.13 2.73% up 340% up United States
14Krystal BiotechKRYS · Health Care23.7PLN 37.1BPLN 1,250.91 4.09% up 46% up United States
15ModernaMRNA · Health Care42.1PLN 329.3BPLN 813.91 2.22% down 755% up United States
16ImmunityBioIBRX · Health Care61.8PLN 28.2BPLN 26.51 5.19% up 193% up United States
17Kymera TherapeuticsKYMR · Health Care262PLN 41.4BPLN 484.95 0.86% down 87% up United States
18CRISPR TherapeuticsCRSP · Health Care1149PLN 16.2BPLN 167.34 3.55% up 21% down Switzerland
19CG OncologyCGON · Health Care1787PLN 29.1BPLN 325.35 2.39% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0252 PLN). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech companies have the lowest P/S ratio?

Biogen (3.7), Qiagen (4.9) and Neurocrine Biosciences (5.8) have the lowest P/S ratio of the 19 biotech companies ranked here as of 18 Nov 2026, 16:47 UTC.

How many biotech companies are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 19 biotech companies ranked by P/S ratio have a combined market value of PLN 3.38T as of 18 Nov 2026, 16:47 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech companies by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.